{"id":33890,"date":"2018-04-16T08:45:34","date_gmt":"2018-04-16T08:45:34","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=33890"},"modified":"2018-04-16T13:18:37","modified_gmt":"2018-04-16T13:18:37","slug":"croi-2018-third-reports","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/33890","title":{"rendered":"CROI 2018: third reports"},"content":{"rendered":"<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-33718\" src=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2018\/03\/croi-2018-logo-2-219x300.png\" alt=\"\" width=\"219\" height=\"300\" srcset=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2018\/03\/croi-2018-logo-2-219x300.png 219w, https:\/\/i-base.info\/htb\/wp-content\/uploads\/2018\/03\/croi-2018-logo-2.png 373w\" sizes=\"auto, (max-width: 219px) 100vw, 219px\" \/>We continue our reports from CROI 2018, which was held this year from 4 &#8211; 7 March in Boston.<\/strong><\/p>\n<p>CROI is one of the most important HIV conferences and comprehensive conference material is available free online.<\/p>\n<p>This includes the full programme and abstracts with webcasts from oral presentations. Approximately 1100 new studies were selected for the conference this year.<\/p>\n<p><a href=\"http:\/\/www.croiconference.org\">http:\/\/www.croiconference.org<\/a><\/p>\n<p><a href=\"http:\/\/www.croiconference.org\/abstracts\/search-abstracts\">http:\/\/www.croiconference.org\/abstracts\/search-abstracts<\/a> (abstracts and posters)<\/p>\n<p><a href=\"http:\/\/www.croiwebcasts.org\">http:\/\/www.croiwebcasts.org<\/a> (webcasts)<\/p>\n<p>Reports from CROI 2018 in this issue include:<\/p>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/33866\" rel=\"bookmark\">No increased risk of IRIS in people with low CD4 counts receiving raltegravir in the REALITY trial<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/33851\" rel=\"bookmark\">Isoniazid preventive TB therapy in pregnancy and postpartum: recommendations now need to be re-evaluated<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/33893\" rel=\"bookmark\">Efavirenz might decrease effectiveness of the vaginal contraceptive ring<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/33884\" rel=\"bookmark\">Switch to TAF appears safe and effective in adolescents: similar PK to adults<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/33859\" rel=\"bookmark\">Doubling raltegravir dose could overcome interaction with rifampicin in children aged 2 to 6<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/33854\" rel=\"bookmark\">Twice-daily bictegravir does not overcome drug interaction with rifampicin<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/33895\" rel=\"bookmark\">Reducing risk of myocardial infarction (MI) in HIV positive people<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/33900\" rel=\"bookmark\">M184V mutation associated with increased risk of viral blip but not viral failure with 3TC-based dual therapy<\/a><\/li>\n<\/ul>\n<p>i-Base reports link to key studies, and hyperlinks take you to the full results. Earlier reports from CROI are included in the <a href=\"https:\/\/i-base.info\/htb\/date\/2018\/03\">March issues of HTB (numbers 5 and 6<\/a>).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We continue our reports from CROI 2018, which was held this year from 4 &#8211; 7 March in Boston. CROI is one of the most important HIV conferences and comprehensive conference material is available free online. This includes the full &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,251],"class_list":["post-33890","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-conference-index","tag-croi-2018"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/33890","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=33890"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/33890\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=33890"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=33890"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=33890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}